Michael E. Newcomb, Michelle Birkett, and Brian Mustanski are with the Department of Medical Social Sciences, Northwestern University, Feinberg School of Medicine, Chicago, IL. Heather L. Corliss is with Children's Hospital of Boston and Harvard Medical School, Boston, MA.
Am J Public Health. 2014 Feb;104(2):304-10. doi: 10.2105/AJPH.2013.301702. Epub 2013 Dec 12.
We evaluated drug use differences between sexual minority and heterosexual students, including interactions with gender and race/ethnicity.
We used 2005 and 2007 Youth Risk Behavior Survey data pooled from Boston, Massachusetts; Chicago, Illinois; Delaware; Maine; Massachusetts; New York City, New York; Rhode Island; and Vermont to evaluate drug use (marijuana, cocaine, inhalants, heroin, methamphetamine, and MDMA [Ecstasy]) using 2 aspects of sexual orientation (identity and sex of sexual partners).
Sexual minority students had higher prevalence of drug use than did heterosexuals on both sexual orientation dimensions, and differences were particularly pronounced among bisexual students on both dimensions. Differences between sexual minority and heterosexual male students in prevalence were generally larger than were differences between sexual minority and heterosexual female students. Racial minority students generally reported lower prevalence of drug use. However, the protective effect of African American race was less pronounced for some sexual minorities.
Sexual minority youths are at increased risk for drug use. Intervention is needed at the institutional and individual levels to address these disparities.
我们评估了性少数群体和异性恋学生之间的药物使用差异,包括与性别和种族/民族的相互作用。
我们使用了 2005 年和 2007 年从马萨诸塞州波士顿、伊利诺伊州芝加哥、特拉华州、缅因州、马萨诸塞州、纽约市、纽约州、罗得岛州和佛蒙特州收集的青年风险行为调查数据,使用性取向的两个方面(身份和性伴侣的性别)来评估药物使用(大麻、可卡因、吸入剂、海洛因、冰毒和摇头丸[摇头丸])。
性少数群体学生在两个性取向维度上的药物使用发生率均高于异性恋者,双性恋学生在两个维度上的差异尤其明显。性少数群体男学生与异性恋男学生在流行率上的差异一般大于性少数群体女学生与异性恋女学生的差异。少数族裔学生的药物使用流行率普遍较低。然而,对于一些性少数群体来说,非裔美国人种族的保护作用不太明显。
性少数群体青年患药物使用障碍的风险增加。需要在机构和个人层面进行干预,以解决这些差异。